Den här översättningen är inte klar ännu. Den här sidan är just nu på engelska.

Gå till den engelska sidan

Massive brazilian registry aims to uncover hidden health risks in HIV patients

NCT ID NCT07118683

What the study statuses mean

This study's is highlighted.

Recruitment status, easiest to join first

Recruiting now This study
This trial is taking on new participants right now.
Not yet recruiting
Registered, but not yet taking participants.
By invitation only
Not open to general applications. Only people the study team invites can take part.
Paused
Paused for now. It may or may not start again.
Ongoing
Running, but no longer taking on new participants.
Completed
The trial has finished. Results may not be published yet.
Stopped early
Stopped early, before it reached the end. That can be for many reasons, including safety.
Cancelled
Cancelled before anyone took part.

Expanded access (not trials)

Expanded access
Not a trial. This treatment can be requested outside a study, case by case, for people who qualify.
Expanded access (paused)
Not a trial. The treatment can normally be requested outside a study, but is unavailable right now.
Expanded access (ended)
Not a trial. The treatment could once be requested outside a study, but no longer can.
Approved
The treatment has been approved, so it is available normally rather than through this programme.

When the status isn't known

Details not published
The full record has not been published yet, so there is little to show here.
Status unknown
This status has not been confirmed recently, so it may be out of date.

First seen Jun 27, 2026 · Last updated Jun 27, 2026

Summary

This study is creating a large database of health information from 743 adults with HIV/AIDS across Brazil. Researchers will look at how common chronic diseases like heart disease, kidney disease, and cancer are in this group. The goal is to gather data to help improve health policies and care for people living with HIV/AIDS.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Study facts

What this study's own registry entry says, in plain language.

Participants

About 743 people

The number the study aims to enrol. It can still change while the study runs.

Started

Aug 2025

Expected to finish

Dec 2026

An estimate. End dates often move.

Lead sponsor

Other sponsor

The registry's catch-all category, for sponsors it does not file as a company, a government agency, or a research network.

Who can take part

This study's own entry requirements. Only the study team can say for certain whether you qualify.

Who is studied

People living with HIV or Aids.

Ages

18 years and older

Sex

Anyone

Healthy volunteers

Not accepted

This study is not open to healthy volunteers. The entry requirements below say who it is open to.

Show the full entry requirements

Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.

Inclusion Criteria: * Adults aged 18 or over; * Confirmed HIV or AIDS diagnosis; * Signature of consent form. Exclusion Criteria: * Indigenous population or those in prison in open or closed regimes; * Patients hospitalized at the time of signing the Consent Form.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for AIDS (acquired immunodeficiency syndrome) are added.

Vår säkerhetsrekommendation!

Genom att skicka in godkänner du våra Användarvillkor

Conditions

The condition(s) this trial relates to.

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

How to take part

Only the study team decides who joins. These are the ways to reach them.

  1. The places running it

    8 sites. The list below names each one and where it is.

  2. The official record

    ClinicalTrials.gov lists the study team's own contact details, including names and phone numbers. We don't republish those.

    Open the record ↗

  3. A doctor treating you

    A doctor who knows your case can contact a study site on your behalf, and can tell you whether this study is worth pursuing at all.

Contacts and locations

Locations

  • Centro Universitário FMABC

    RECRUITING

    Santo André, São Paulo, Brazil

  • Centro de Pesquisa Clínica Dom Bosco

    RECRUITING

    Araçatuba, São Paulo, Brazil

  • Faculdade de Medicina da Universidade Federal de Minas Gerais

    ACTIVE_NOT_RECRUITING

    Belo Horizonte, Minas Gerais, Brazil

  • Faculdade de Medicina de Botucatu da UNESP

    NOT_YET_RECRUITING

    Botucatu, São Paulo, Brazil

  • Hospital Federal de Santa Maria

    RECRUITING

    Santa Maria, Rio Grande do Sul, Brazil

  • Hospital Federal dos Servidores do Estado do Rio de Janeiro

    RECRUITING

    Rio de Janeiro, Rio de Janeiro, Brazil

  • Hospital das Clínicas da Universidade Federal de Goiás

    RECRUITING

    Goiânia, Goiás, Brazil

  • Hospital de Clínicas da Universidade Federal do Paraná

    RECRUITING

    Curitiba, Paraná, Brazil

  • Instituto de Infectologia Emílio Ribas

    RECRUITING

    São Paulo, São Paulo, Brazil

More trials for these conditions

Other studies related to the condition(s) this trial covers.